With a little momentum at the end of 2018, Pfizer Inc. (NYSE:PFE) could be headed for its best year yet in the 21st century. The big pharma stock is absolutely crushing the performance of the overall market.It's not that Pfizer's sales are soaring. The drugmaker missed analyst revenue estimates...
Two drug stocks diverged in a yellow wood. And sorry I could not buy both and be one investor, long I stood.My apologies to Robert Frost for butchering his famous poem "The Road Not Taken." But Celgene Corporation (NASDAQ:CELG) and Merck & Co. (NYSE:MRK) certainly are two drug stocks headed...
Over the past several years, rumors have spread that Apple (NASDAQ:AAPL) is working on a secret car initiative called Project Titan that could launch the company squarely into the autonomous vehicle market -- when and if Titan comes to market.The narrative surrounding Apple's car project has shifted several times....
Coffee giant Starbucks (NASDAQ:SBUX) recently wrapped up its fiscal 2018 on an upbeat note, posting better-than-expected revenue and earnings per share in its fiscal fourth quarter. The period was fueled by strong comparable store sales momentum, new store openings, and further growth in the company's loyalty program.To fully appreciate...
If youth is wasted on the young, you might say retirement is wasted on the old. Leaving the workforce behind is a worthy financial goal, but it can be discouraging to realize you'll probably be covered in wrinkles and liver spots by the time you get there.That's why some...
Walmart (NYSE:WMT) has big plans for its Supercenters. At the recent International Council of Shopping Centers Southeast Conference and Deal Making event, Walmart's president of U.S. realty operations, L. B. Johnson, noted the company is looking to create upscale town centers around certain Supercenters."We want to provide community space,...
You'd be tempted to think that there was something terribly wrong at Roku (NASDAQ:ROKU) if you looked solely at the stock price. The streaming platform and pioneer is down 14% year to date, which doesn't compare favorably to the 1% gain managed by the S&P 500.Taken in a vacuum, the...
It has been a volatile year for Activision Blizzard (NASDAQ:ATVI) shareholders, with the stock having logged market-thumping gains through the summer before falling to a 19% decline as we approach the end of 2018. Of course, the video game developer's business value hasn't changed by nearly that much. Instead, the...
Last year, chip giant Intel (NASDAQ:INTC) introduced a new platform for the high-end desktop (HEDT) market called Basin Falls. The Basin Falls platform incorporated the company's then-new Skylake-X chips (marketed as Core X series processors) -- which were derived from the company's data center-oriented Skylake-SP processors -- as well as a platform...
The recent market decline has been particularly tough on tech stocks, and Netflix (NASDAQ:NFLX) has been no exception. Since topping out in early July, the streaming giant has lost nearly a third of its value. The market's uncertainty continues, and given that reality, it might seem like an unlikely...